当前位置：
X-MOL 学术
›
Nat. Rev. Immunol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
SARS-CoV-2 hybrid immunity: silver bullet or silver lining?
Nature Reviews Immunology ( IF 67.7 ) Pub Date : 2022-08-09 , DOI: 10.1038/s41577-022-00771-8 Rahul Suryawanshi 1 , Melanie Ott 1, 2, 3
Nature Reviews Immunology ( IF 67.7 ) Pub Date : 2022-08-09 , DOI: 10.1038/s41577-022-00771-8 Rahul Suryawanshi 1 , Melanie Ott 1, 2, 3
Affiliation
|
Hybrid immunity occurs in those who have been both infected with and vaccinated against SARS-CoV-2. But how well does such hybrid immunity protect against the virus and its emerging variants?
中文翻译：
SARS-CoV-2 混合免疫：灵丹妙药还是一线希望？
混合免疫发生在那些既感染过 SARS-CoV-2 又接种过 SARS-CoV-2 疫苗的人身上。但这种混合免疫对病毒及其新出现的变种的防护效果如何？
更新日期：2022-08-10
中文翻译：
SARS-CoV-2 混合免疫：灵丹妙药还是一线希望？
混合免疫发生在那些既感染过 SARS-CoV-2 又接种过 SARS-CoV-2 疫苗的人身上。但这种混合免疫对病毒及其新出现的变种的防护效果如何？
京公网安备 11010802027423号